Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?

References

• Antinori A, Giancola ML, Grisetti S, Soldani F, Alba L, Liuzzi G, Amendola A, Capobianchi M, Tozzi V, Perno CF (2002). Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS 16: 1867–1876.
   PubMed Web of Science ®Google Scholar
• Aquaro S, Calio R, Balzarini J, Bellocchi MC, Garaci E, Perno CF (2002). Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Res 55: 209–255.
   PubMed Web of Science ®Google Scholar
• Aulitzky WE, Tilg H, Vogel W, et al (1991). Acute hemato-logic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2. Ann Hematol 62: 25–31.
   PubMed Web of Science ®Google Scholar
• Boase S, Miners JO (2002). In vitro–in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. Br J Clin Pharmacol 54: 493–503.
   PubMed Web of Science ®Google Scholar
• Brew BJ (2001). AIDS dementia complex. In: HIV neurology. Oxford, UK: Oxford University Press, pp 53–90.
   Google Scholar
• Cunningham P, Smith D, Satchell C, Cooper DA, Brew BJ (2000). Evidence for independent development of reverse transcriptase inhibitor resistance patterns in the cerebrospinal fluid. AIDS 14: 1949–1954.
   PubMed Web of Science ®Google Scholar
• Gao WY, Agbaria R, Driscoll JS, Mitsuya H (1994). Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. J Biol Chem 269: 12633–12638.
   PubMed Web of Science ®Google Scholar
• Gartner S, Liu Y (2002). Insights into the role of immune activation in HIV neuropathogenesis. J NeuroVirol 8: 69–75.
   PubMed Web of Science ®Google Scholar
• Hoggard PG, Kewn S, Barry MG, Khoo SH, Back DJ (1997). Effects of drugs on 2′,3′,-dideoxy-2′,3′-dideohydrothymidine phosphorylation in vitro. Antimicrob Agents Chemother 41: 1231–1236.
   PubMed Web of Science ®Google Scholar
• Huisman MT, Smit JW, Crommentuyn KM, Zelcer N, Wiltshire HR, Beijnen JH, Schinkel AH (2002). Multidrug resistance protein 2 (MRP2) transports HIV pro-tease inhibitors, and transport can be enhanced by other drugs. AIDS 16: 2295–2301.
   PubMed Web of Science ®Google Scholar
• Kerr SJ, Armati PJ, Pemberton LA, Smythe G, Tattam B, Brew BJ (1997). Kynurenine pathway inhibition reduces toxicity of HIV-infected macrophages. Neurology 49: 1671–1681.
   PubMed Web of Science ®Google Scholar
• Lanier RE, Sturge G, McClernon D, Brown S, Halman M, Sacktor N, McArthur J, Atkinson JH, Clifford D, Price RW, Simpson D, Torres G, Catalan J, Marder K, Power C, Hall C, Romero C, Brew BJ (2001). HIV-1 reverse transcriptase sequence and HIV-1 RNA response to abacavir in plasma and CSF of subjects with AIDS dementia complex. AIDS 15: 747– 751.
   Google Scholar
• Mir N, Costello C, Luckit J, Lindley R (1989). HIV-disease and bone marrow changes: a study of 60 cases. Eur J Haematol 42: 339–343.
   PubMed Web of Science ®Google Scholar
• Moore KHP, Barrett JE, Shaw S, et al (1999). The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. AIDS 13: 2239–2250.
   PubMed Web of Science ®Google Scholar
• O’Brien WA, Namazi A, Kalhor H, Mao S-H, Zack JA, Chen ISY (1994). Kinetic of human immunodeficiency virus type 1 reverse transcriptase in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol 68: 1258–1263.
   PubMed Web of Science ®Google Scholar
• Sacktor N, Tarwater PM, Skolasky RL, McArthur JC, Selnes OA, Becker J, Cohen B, Miller EN; Multi-center for AIDS Cohort Study (MACS) (2001). CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology 57: 542–544.
   PubMedGoogle Scholar
• Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A (2000). Bio-analytical method validation—a revisit with a decade of progress. Pharm Res 17: 1551–1557.
   PubMedGoogle Scholar
• Stein DS, Moore KH (2001). Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians. Pharmacotherapy 21: 11–34.
   Google Scholar
• Treacy M, Lai L, Costello C, Clark A (1987). Peripheral blood and bone marrow abnormalities in patients with HIV related disease. Br J Haematol 65: 289– 294.
   Google Scholar
• Venturi G, Catucci M, Romano L, Corsi P, Leoncini F, Valensin PE, Zazzi M (2000). Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J Infect Dis 181: 740–745.
   PubMed Web of Science ®Google Scholar